Mode of Childbirth and Long-Term Outcomes in Women with Inflammatory Bowel Diseases

Digestive Diseases and Sciences

Volumn 60, Issue 2, 2015, Pages 471-477

  Ananthakrishnan, Ashwin N ^a,b   Cheng, Alice ^a   Cagan, Andrew ^c   Cai, Tianxi ^d   Gainer, Vivian S ^c   Shaw, Stanley Y ^a,b   Churchill, Susanne ^e   Karlson, Elizabeth W ^b,e   Murphy, Shawn N ^a,b,e   Kohane, Isaac ^b,e,f   Liao, Katherine P ^b,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PARTNERS HEALTHCARE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Caesarean section; Crohn s disease; Delivery; Pregnancy; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CERTOLIZUMAB PEGOL; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR; IMMUNOLOGIC FACTOR;

ADULT; ANUS FISTULA; ARTICLE; CESAREAN SECTION; CHILDBIRTH; CROHN DISEASE; FEMALE; FOLLOW UP; GROUPS BY AGE; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; INFLAMMATORY BOWEL DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; ULCERATIVE COLITIS; VAGINAL DELIVERY; ABDOMINAL SURGERY; ADOLESCENT; ADVERSE EFFECTS; BIRTH; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COLITIS, ULCERATIVE; COMPARATIVE STUDY; COMPLICATION; DISEASE COURSE; HOSPITAL READMISSION; KAPLAN MEIER METHOD; MASSACHUSETTS; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OBSTETRIC DELIVERY; PROCEDURES; PROGNOSIS; RECTAL FISTULA; RISK FACTOR; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; BOSTON; CESAREAN SECTION; CHI-SQUARE DISTRIBUTION; COLITIS, ULCERATIVE; CROHN DISEASE; DELIVERY, OBSTETRIC; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARTURITION; PATIENT READMISSION; PREGNANCY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL FISTULA; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84921783728     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3353-6     Document Type: Article

References (35)

1. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794.
2. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:1–20.
3. Mountifield RE, Prosser R, Bampton P, et al. Pregnancy and IBD treatment: this challenging interplay from a patients’ perspective. J Crohns Colitis. 2010;4:176–182.
4. Selinger CP, Eaden J, Selby W, et al. Patients’ knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool (‘CCPKnow’). Aliment Pharmacol Ther. 2012;36:57–63.
5. Selinger CP, Eaden J, Selby W, et al. Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis. 2013;7:e206–e213.
6. Agret F, Cosnes J, Hassani Z, et al. Impact of pregnancy on the clinical activity of Crohn’s disease. Aliment Pharmacol Ther. 2005;21:509–513.
7. Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch Gynecol Obstet. 2004;270:79–85.
8. Friedman S, Regueiro MD. Pregnancy and nursing in inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:265–273, xii.
9. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease—a population-based cohort study. Am J Obstet Gynecol. 1997;177:942–946.
10. Mahadevan U, Cucchiara S, Hyams JS, et al. The London position statement of the world congress of gastroenterology on biological therapy for IBD with the European Crohn’s and colitis organisation: pregnancy and pediatrics. Am J Gastroenterol. 2011;106:214–223; quiz 224.
11. Ng SW, Mahadevan U. Management of inflammatory bowel disease in pregnancy. Expert Rev Clin Immunol. 2013;9:161–173; quiz 174.
12. Rogers RG, Katz VL. Course of Crohn’s disease during pregnancy and its effect on pregnancy outcome: a retrospective review. Am J Perinatol. 1995;12:262–264.
13. Huang VW, Habal FM. From conception to delivery: managing the pregnant inflammatory bowel disease patient. World J Gastroenterol. 2014;20:3495–3506.
14. Mahadevan U, Sandborn WJ, Li DK, et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007;133:1106–1112.
15. Selinger CP, Leong RW, Lal S. Pregnancy related issues in inflammatory bowel disease: evidence base and patients’ perspective. World J Gastroenterol. 2012;18:2600–2608.
16. Gisbert JP, Chaparro M. Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease. Am J Gastroenterol. 2013;108:1426–1438.
17. Hutson JR, Matlow JN, Moretti ME, et al. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. J Obstet Gynaecol. 2013;33:1–8.
18. Saha S, Wald A. Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease. Expert Opin Drug Saf. 2012;11:947–957.
19. Allen VM, Baskett TF, O’Connell CM. Contribution of select maternal groups to temporal trends in rates of caesarean section. J Obstet Gynaecol Can. 2010;32:633–641.
20. Fairley L, Dundas R, Leyland AH. The influence of both individual and area based socioeconomic status on temporal trends in Caesarean sections in Scotland 1980–2000. BMC Public Health. 2011;11:330.
21. Roberts CL, Algert CS, Carnegie M, et al. Operative delivery during labour: trends and predictive factors. Paediatr Perinat Epidemiol. 2002;16:115–123.
22. Manosa M, Navarro-Llavat M, Marin L, et al. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey. Scand J Gastroenterol. 2013;48:427–432.
23. Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56:830–837.
24. Hatch Q, Champagne BJ, Maykel JA, et al. Crohn’s disease and pregnancy: the impact of perianal disease on delivery methods and complications. Dis Colon Rectum. 2014;57:174–178.
25. Ilnyckyji A, Blanchard JF, Rawsthorne P, et al. Perianal Crohn’s disease and pregnancy: role of the mode of delivery. Am J Gastroenterol. 1999;94:3274–3278.
26. Smink M, Lotgering FK, Albers L, et al. Effect of childbirth on the course of Crohn’s disease; results from a retrospective cohort study in the Netherlands. BMC Gastroenterol. 2011;11:6.
27. Brandt LJ, Estabrook SG, Reinus JF. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn’s disease. Am J Gastroenterol. 1995;90:1918–1922.
28. Ananthakrishnan AN, Cagan A, Gainer VS, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease. Inflamm Bowel Dis. 2013;19:1921–1927.
29. Ananthakrishnan AN, Cagan A, Gainer VS, et al. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease. J Crohns Colitis. 2014;8:956–963.
30. Ananthakrishnan AN, Cai T, Savova G, et al. Improving case definition of Crohn’s disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach. Inflamm Bowel Dis. 2013;19:1411–1420.
31. Ananthakrishnan AN, Cheng SC, Cai T, et al. Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12:1342–1348.
32. Ananthakrishnan AN, Cheng SC, Cai T, et al. Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12:821–827.
33. Ananthakrishnan AN, Gainer VS, Perez RG, et al. Psychiatric co-morbidity is associated with increased risk of surgery in Crohn’s disease. Aliment Pharmacol Ther. 2013;37:445–454.
34. Landon MB, Hauth JC, Leveno KJ, et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med. 2004;351:2581–2589.
35. Cheng AG, Oxford EC, Sauk J, et al. The impact of mode of delivery on outcomes in patients with perianal Crohn’s disease. Inflamm Bowel Dis. 2014;20:1391–1398.